VANDELLI, Maria Angela
 Distribuzione geografica
Continente #
NA - Nord America 22.658
EU - Europa 14.030
AS - Asia 3.605
SA - Sud America 92
AF - Africa 38
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 26
Totale 40.476
Nazione #
US - Stati Uniti d'America 22.569
GB - Regno Unito 5.243
IT - Italia 3.780
SE - Svezia 1.664
CN - Cina 1.204
DE - Germania 876
HK - Hong Kong 721
TR - Turchia 706
UA - Ucraina 695
SG - Singapore 493
FI - Finlandia 421
FR - Francia 321
BG - Bulgaria 290
IN - India 135
RO - Romania 101
IE - Irlanda 96
RU - Federazione Russa 95
BE - Belgio 82
NL - Olanda 68
CA - Canada 64
KR - Corea 56
CH - Svizzera 47
ID - Indonesia 47
IR - Iran 44
LT - Lituania 42
JP - Giappone 41
ES - Italia 37
VN - Vietnam 36
MY - Malesia 32
BR - Brasile 30
CZ - Repubblica Ceca 30
PL - Polonia 29
EU - Europa 23
AU - Australia 22
IL - Israele 21
PT - Portogallo 21
GR - Grecia 20
CL - Cile 18
AT - Austria 16
MX - Messico 15
PK - Pakistan 14
TW - Taiwan 14
HU - Ungheria 13
PE - Perù 13
MD - Moldavia 12
EG - Egitto 11
TH - Thailandia 11
AR - Argentina 10
CO - Colombia 10
IQ - Iraq 10
EC - Ecuador 9
ZA - Sudafrica 8
SN - Senegal 7
SI - Slovenia 6
BZ - Belize 5
DK - Danimarca 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
RS - Serbia 5
AN - Antille olandesi 4
BY - Bielorussia 4
MA - Marocco 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
KE - Kenya 3
YE - Yemen 3
A2 - ???statistics.table.value.countryCode.A2??? 2
DZ - Algeria 2
NG - Nigeria 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
AP - ???statistics.table.value.countryCode.AP??? 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CR - Costa Rica 1
GH - Ghana 1
HR - Croazia 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MT - Malta 1
VE - Venezuela 1
Totale 40.476
Città #
Southend 4.606
Fairfield 2.819
Chandler 2.166
Woodbridge 2.027
Ashburn 1.749
Jacksonville 1.527
Houston 1.372
Seattle 1.178
Dearborn 1.130
Wilmington 1.094
Ann Arbor 1.073
Nyköping 1.028
Cambridge 942
Hong Kong 711
Modena 607
Izmir 456
Beijing 426
Princeton 313
Chicago 312
Singapore 295
Sofia 286
Eugene 264
San Diego 263
New York 199
Milan 190
Redwood City 185
Helsinki 176
Des Moines 169
Rome 158
Bologna 127
Bremen 123
London 113
Fremont 110
Falls Church 81
Dublin 78
Boardman 77
Brussels 77
Shanghai 71
Hefei 61
Parma 57
Como 51
Norwalk 48
Naples 46
Reggio Emilia 43
Nanjing 42
Jakarta 39
Florence 38
Kunming 38
Tulare 38
Los Angeles 37
Bari 34
Turin 34
Frankfurt am Main 33
Napoli 33
Milwaukee 32
Guangzhou 31
Mountain View 30
San Giuliano Milanese 29
Catania 27
Dallas 27
Indiana 27
San Mateo 27
Jinan 25
Verona 24
Genoa 23
Hounslow 23
Kilburn 21
Palermo 21
Washington 21
Ferrara 20
Padova 20
Dong Ket 19
Auburn Hills 18
Munich 18
Kocaeli 17
Philadelphia 17
Tokyo 17
Toronto 17
Wuhan 17
Hangzhou 16
Phoenix 16
Bengaluru 15
Brno 15
Prescot 15
Hanoi 14
Mumbai 14
Perugia 14
Dongguan 13
Fuzhou 13
Istanbul 13
Saint Petersburg 13
Chisinau 12
Chiswick 12
Halifax 12
Limerick 12
Nanchang 12
Paris 12
Reggio Nell'emilia 12
Sassuolo 12
Zhengzhou 12
Totale 30.097
Nome #
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 364
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 334
A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Δ9-tetrahydrocannabinol: Δ9-Tetrahydrocannabiphorol 305
Analysis of cannabinoids in commercial hemp seed oil and decarboxylation kinetics studies of cannabidiolic acid (CBDA) 287
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 281
Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates 279
Development of a simple and sensitive liquid chromatography triple quadrupole mass spectrometry (LC–MS/MS) method for the determination of cannabidiol (CBD), Δ9-tetrahydrocannabinol (THC) and its metabolites in rat whole blood after oral administration of a single high dose of CBD 273
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 264
Medicinal cannabis: Principal cannabinoids concentration and their stability evaluated by a high performance liquid chromatography coupled to diode array and quadrupole time of flight mass spectrometry method 252
Protein corona and nanoparticles: How can we investigate on? 246
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 244
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 238
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 236
Nanoparticle transport across the blood brain barrier 230
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 230
Distribution of drugs in polymers loaded by swelling 227
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 227
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 226
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 226
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 222
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 221
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 221
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 216
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 215
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 214
Pharmaceutical and biomedical analysis of cannabinoids: A critical review 213
Dotap/Udca vesicles: novel approach in oligonucleotide delivery 212
Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles 210
Use of Polylactide-Co-Glycolide-Nanoparticles for Lysosomal Delivery of a Therapeutic Enzyme in Glycogenosis Type II Fibroblasts 209
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 208
AFM phase imaging of soft-hydrated samples: A versatile tool to complete the chemical-physical study of liposomes 208
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 207
The grinding of the polymorphic forms of chloramphenicol stearic ester in the presence of colloidal silica 206
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 206
The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system 202
PLGA nanoparticles surface decorated with the sialic acid, N-acetylneuraminic acid 201
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 199
Properties of tolmetin-loaded Eudragit RL100 and Eudragit RS100 microparticles prepared by different techniques 198
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 197
Untargeted rat brain metabolomics after oral administration of a single high dose of cannabidiol 197
Nanoimaging: photophysical and pharmaceutical characterization of poly-lactide-co-glycolide nanoparticles engineered with quantum dots 196
Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution 194
A Metabolomic Approach Applied to a LiquidChromatography Coupled to High-ResolutionTandem Mass Spectrometry Method (HPLC-ESI-HRMS/MS): Towards the ComprehensiveEvaluation of the Chemical Composition ofCannabis Medicinal Extracts 193
Sistema di veicolazione e rilascio di farmaci antiparassitari e loro uso in campo medico 192
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 192
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 192
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 191
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 191
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 190
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 190
The novel heptyl phorolic acid cannabinoids content in different Cannabis sativa L. accessions 189
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences. 187
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 186
Analysis of impurities of cannabidiol from hemp. Isolation, characterization and synthesis of cannabidibutol, the novel cannabidiol butyl analog 186
Cannabinoid profiling of hemp seed oil by liquid chromatography coupled to high-resolution mass spectrometry 185
Peptide-engineered polylactide-co-glycolide (PLGA) nanoparticles for brain delivery of drugs: in vivo experiments and proof of concept 183
A theoretical model for the calculation of the drug distribution profile in matrices of different shape to achieve the desired drug release kinetics 183
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 182
NIR-labeled nanoparticles engineered for brain targeting: in vivo optical imaging application and fluorescent microscopy evidences. 182
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 182
Colloidal systems for CNS drug delivery 181
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 181
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 180
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 180
Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery across the Blood-Brain Barrier 180
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 179
Effect of the loading method on the drug release from cross-linked carboxymethylcellulose beads 179
Solid state transitions and CAP availability in surface solid dispersions of chloramphenicol stearate polymorphs 178
Functionalization of liposomes: microscopical methods for preformulative screening 177
EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION 177
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 177
Bead coating process via an excess of crosslinking agent 176
THE INTERACTION OF BILIAR ACIDS WITH 2-HYDROXYPROPYL-CYCLODEXTRIN IN SOLUTION AND IN THE SOLID STATE 176
Nanoparticles as Blood–Brain Barrier Permeable CNS Targeted Drug Delivery Systems 176
Nanoparticles Loaded with Nutlin-3 Display Cytotoxicity Towards p53wildtype JVM-2 But Not Towards p53mutated BJAB Leukemic Cells 175
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution 174
Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier 174
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 172
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 171
Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain 170
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 170
NANOPARTICELLE POLIMERICHE PER IL DIREZIONAMENTO CEREBRALE: DELIVERY DI ZINCO E STUDI PRELIMINARI IN VITRO SU CELLULE NEURONALI 169
Glycopeptide-decorated nanoparticles as drug carriers for CNS: effects of surface coverage and carbohydrate type 169
Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy 169
Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures 168
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 168
Studi preformulativi sul complesso di inclusione tra acido ursodesossicolico e beta-ciclodestrine 168
Chemical and spectroscopic characterization data of ‘cannabidibutol’, a novel cannabidiol butyl analog 168
AN INTERPRETATIVE ANALYSIS OF THE EFFECT OF THE SURFACTANTS USED FOR THE PREPARATION OF POLYALKYLCYANOACRYLATE NANOPARTICLES ON THE RELEASE PROCESS 167
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 166
Doxorubicin-loaded gelatin nanoparticles stabilized by glutaraldehyde: Involvement of the drug in the cross-linking process 166
Preparazione e caratterizzazione del complesso tra acido iodesossicolico e 2-idrossipropil-beta-ciclodestrina 166
Detection of PLGA-based nanoparticles at single cell level by Synchrotron Radiation FTIR Spectromicroscopy and correlation with X-Ray Fluorescence Microscopy 166
STUDIO TECNOLOGICO DI OTTIMIZZAZIONE DI SISTEMI NANOPARTICELLARI ALLESTITI IN EMULSIONE SEMPLICE 165
Polymeric nanoparticles for the drug delivery to the central nervous system 164
Ketorolac tromethamine liposomes: Encapsulation and release studies 163
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 162
Brain-targeted polymeric nanoparticles: in vivo evidences after different routes of administration in rodents. 161
Brain targeting with polymeric nanoparticles: which administration route should we take? 160
Atomic force microscopy and photon correlation spectroscopy: Two techniques for rapid characterization of liposomes 160
Totale 19.965
Categoria #
all - tutte 163.294
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 163.294


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207.755 0 476 264 505 959 1.087 1.383 911 976 321 516 357
2020/20217.353 996 294 524 651 720 458 599 865 315 1.107 454 370
2021/20225.454 242 633 533 395 201 251 288 344 626 403 891 647
2022/20236.359 751 688 500 621 732 933 171 561 734 117 244 307
2023/20244.469 224 264 273 353 912 463 524 576 161 139 209 371
2024/2025840 758 82 0 0 0 0 0 0 0 0 0 0
Totale 40.960